Cardiovasc Diabetol. 2024 Dec 21;23(1):452.doi: 10.1186/s12933-024-02545-z. (IF:8.57).
2024-12-21Cardiovasc Diabetol. 2024 Dec 21;23(1):452.doi: 10.1186/s12933-024-02545-z. ANXA1-FPR2 axis mitigates the susceptibility to atrial fibrillation in obesity via rescuing AMPK activity in response to lipid overload ANXA1-FPR2轴通过拯救AMPK活性以应对脂质超载来减轻肥胖患者对房颤的易感性 (IF:8.57).